Neuroendokrin daganatok: vizsgálatok itt: Ausztrália
10 trials · From ClinicalTrials.gov, checked 2026. november 15.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Parkville, Randwick
- Életkor
- 12 év and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00 - 2. fázisTaking peopleCessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours
- Where
- Adelaide, Brisbane, Cairns, Kalgoorlie-Boulder, Melbourne, Perth, Sydney, Toowoomba, Wollongong
- Életkor
- 18 év and over
- People
- 78 worldwide
- Run by
- Australasian Gastro-Intestinal Trials Group
See details and how to joinNCT06345079 - 1/2. fázisNot yet taking people in AusztráliaDAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Camperdown, St Leonards
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895 · EU 2026-525634-27-00 - 3. fázisTaking peopleDAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Bedford Park, Melbourne, Murdoch, St Leonards
- Életkor
- 18 év and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654 · EU 2025-523869-22-00 - 2/3. fázisTaking peopleZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Clayton, Herston, Melbourne, Murdoch, St Leonards, Woodville South
- Életkor
- 18 év and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755 · EU 2025-521043-20-00 - 1. fázisTaking peopleTLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
- Where
- Camperdown, Malvern, Nedlands
- Életkor
- 18 év and over
- People
- 120
- Run by
- Treeline Biosciences, Inc.
See details and how to joinNCT07713732 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Clayton, Hunter Regional Mail Centre, North Adelaide, Parkville, Perth, Randwick, Saint Hobart, South Brisbane, Westmead
- Életkor
- Up to 25 év
- People
- 75 000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - 1. fázisTaking peopleSapu003 in Advanced mTOR-sensitive Solid Tumors
- Where
- Adelaide
- Életkor
- 18 év and over
- People
- 27
- Run by
- SAPU NANO (US) LLC
See details and how to joinNCT07369505 - No phaseTaking peopleThe Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
- Where
- Sydney
- Életkor
- 18 év and over
- People
- 500
- Run by
- Western Sydney Local Health District
See details and how to joinNCT05804331 - 1. fázisTaking peoplePARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
- Where
- Melbourne
- Életkor
- 18 év and over
- People
- 24
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT05053854